A detailed history of Centiva Capital, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 4,568 shares of MRNA stock, worth $168,330. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,568
Previous 3,600 26.89%
Holding current value
$168,330
Previous $427,000 28.57%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $318 - $625
-5 Reduced 0.11%
4,568 $305,000
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $462,833 - $761,907
4,573 New
4,573 $543,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $44,694 - $67,148
643 Added 233.82%
918 $91,000
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $1.75 Million - $2.29 Million
-18,112 Reduced 98.5%
275 $28,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $976,677 - $1.32 Million
8,242 Added 81.24%
18,387 $2.23 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $761,459 - $1.11 Million
-5,613 Reduced 35.62%
10,145 $1.56 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $447,476 - $793,951
-3,780 Reduced 19.35%
15,758 $2.83 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $2.21 Million - $3.64 Million
18,728 Added 2312.1%
19,538 $2.31 Million
Q2 2022

Aug 17, 2022

SELL
$117.13 - $176.59 $22.7 Million - $34.3 Million
-194,200 Reduced 99.58%
810 $116,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $18.8 Million - $28.4 Million
160,626 Added 467.15%
195,010 $27.9 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $4.19 Million - $7.79 Million
33,155 Added 2697.72%
34,384 $5.92 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $3.48 Million - $7.6 Million
-15,693 Reduced 92.74%
1,229 $473,000
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $1.85 Million - $3.15 Million
16,922 New
16,922 $2.22 Million
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $224,587 - $392,015
-4,133 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $122,626 - $330,640
4,133 New
4,133 $265,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.